Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial.
Moreno V, Barretina-Ginesta MP, García-Donas J, Jayson GC, Roxburgh P, Vázquez RM, Michael A, Antón-Torres A, Brown R, Krige D, Champion B, McNeish I. Moreno V, et al. Among authors: brown r. J Immunother Cancer. 2021 Dec;9(12):e003645. doi: 10.1136/jitc-2021-003645. J Immunother Cancer. 2021. PMID: 34893524 Free PMC article. Clinical Trial.
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR).
O'Cathail SM, Davis S, Holmes J, Brown R, Fisher K, Seymour L, Adams R, Good J, Sebag-Montefiore D, Maughan T, Hawkins MA. O'Cathail SM, et al. Among authors: brown r. Radiat Oncol. 2020 Jun 12;15(1):151. doi: 10.1186/s13014-020-01593-5. Radiat Oncol. 2020. PMID: 32532291 Free PMC article. Clinical Trial.
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: brown r. Lancet. 2021 Apr 10;397(10282):1363-1374. doi: 10.1016/S0140-6736(21)00247-6. Lancet. 2021. PMID: 33838757 Free PMC article. Clinical Trial.
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. Marson A, et al. Among authors: brown r. Lancet. 2021 Apr 10;397(10282):1375-1386. doi: 10.1016/S0140-6736(21)00246-4. Lancet. 2021. PMID: 33838758 Free PMC article. Clinical Trial.
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Marson AG, et al. Among authors: brown r. Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750. Health Technol Assess. 2021. PMID: 34931602 Free article. Clinical Trial.
Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study.
Switzer AR, Charidimou A, McCarter S, Vemuri P, Nguyen AT, Przybelski SA, Lesnick TG, Rabinstein AA, Brown RD, Knopman DS, Petersen RC, Jack CR Jr, Reichard RR, Graff-Radford J. Switzer AR, et al. Among authors: brown rd. Neurology. 2024 May 28;102(10):e209386. doi: 10.1212/WNL.0000000000209386. Epub 2024 May 6. Neurology. 2024. PMID: 38710005
Voices of Identity: Exploring Identity Development and Transformation among Urban American Indian/Alaska Native Emerging Adults.
Malika N, Palimaru AI, Rodriguez A, Brown R, Dickerson DL, Holmes P, Kennedy DP, Johnson CL, Sanchez VA, Schweigman K, Klein DJ, D'Amico EJ. Malika N, et al. Among authors: brown r. Identity (Mahwah, N J). 2024;24(2):112-138. doi: 10.1080/15283488.2023.2300075. Epub 2024 Jan 8. Identity (Mahwah, N J). 2024. PMID: 38699070 Free PMC article.
A US perspective on closing the carbon cycle to defossilize difficult-to-electrify segments of our economy.
Shaw WJ, Kidder MK, Bare SR, Delferro M, Morris JR, Toma FM, Senanayake SD, Autrey T, Biddinger EJ, Boettcher S, Bowden ME, Britt PF, Brown RC, Bullock RM, Chen JG, Daniel C, Dorhout PK, Efroymson RA, Gaffney KJ, Gagliardi L, Harper AS, Heldebrant DJ, Luca OR, Lyubovsky M, Male JL, Miller DJ, Prozorov T, Rallo R, Rana R, Rioux RM, Sadow AD, Schaidle JA, Schulte LA, Tarpeh WA, Vlachos DG, Vogt BD, Weber RS, Yang JY, Arenholz E, Helms BA, Huang W, Jordahl JL, Karakaya C, Kian KC, Kothandaraman J, Lercher J, Liu P, Malhotra D, Mueller KT, O'Brien CP, Palomino RM, Qi L, Rodriguez JA, Rousseau R, Russell JC, Sarazen ML, Sholl DS, Smith EA, Stevens MB, Surendranath Y, Tassone CJ, Tran B, Tumas W, Walton KS. Shaw WJ, et al. Among authors: brown rc. Nat Rev Chem. 2024 May 1. doi: 10.1038/s41570-024-00587-1. Online ahead of print. Nat Rev Chem. 2024. PMID: 38693313 Review.
14,425 results
You have reached the last available page of results. Please see the User Guide for more information.